251 related articles for article (PubMed ID: 10682448)
21. The prevalence of antiphospholipid antibodies in cases of recurrent pregnancy loss.
Chakrabarti S; Bhunia C; Bhattacharya DK
J Assoc Physicians India; 1999 May; 47(5):496-8. PubMed ID: 10778558
[TBL] [Abstract][Full Text] [Related]
22. Antiphospholipid antibodies and fetal death.
Oshiro BT; Silver RM; Scott JR; Yu H; Branch DW
Obstet Gynecol; 1996 Apr; 87(4):489-93. PubMed ID: 8602296
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of antiphospholipid antibodies among women experiencing unexplained infertility and recurrent implantation failure.
Sauer R; Roussev R; Jeyendran RS; Coulam CB
Fertil Steril; 2010 May; 93(7):2441-3. PubMed ID: 19962695
[TBL] [Abstract][Full Text] [Related]
24. The association of antiphospholipid antibodies with intrauterine fetal death: a case-control study.
Helgadottir LB; Skjeldestad FE; Jacobsen AF; Sandset PM; Jacobsen EM
Thromb Res; 2012 Jul; 130(1):32-7. PubMed ID: 22178574
[TBL] [Abstract][Full Text] [Related]
25. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
26. The influence of antiphospholipid antibodies on the pregnancy outcome of patients with recurrent spontaneous abortion.
Heilmann L; von Tempelhoff GF; Kuse S
Clin Appl Thromb Hemost; 2001 Oct; 7(4):281-5. PubMed ID: 11697709
[TBL] [Abstract][Full Text] [Related]
27. Autoimmune causes of recurrent pregnancy loss.
Festin MR; Limson GM; Maruo T
Kobe J Med Sci; 1997 Oct; 43(5):143-57. PubMed ID: 9642970
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss.
Mtiraoui N; Borgi L; Hizem S; Nsiri B; Finan RR; Gris JC; Almawi WY; Mahjoub T
Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):164-70. PubMed ID: 15808373
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of immunoglobulin classes of five anti-phospholipid antibodies in sera from patients with SLE, ITP and recurrent fetal abortion by enzyme linked immunosorbent assay].
Hayashi S; Kiyokawa T; Aochi H; Nagamine K; Oshida M; Mizutani H; Tomiyama Y; Kurata Y
Rinsho Byori; 1996 Feb; 44(2):169-75. PubMed ID: 8851202
[TBL] [Abstract][Full Text] [Related]
30. Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who have negative test results for lupus anticoagulant and anticardiolipin antibodies.
Silver RM; Pierangeli SS; Edwin SS; Umar F; Harris EN; Scott JR; Branch DW
Am J Obstet Gynecol; 1997 Mar; 176(3):628-33. PubMed ID: 9077618
[TBL] [Abstract][Full Text] [Related]
31. Protean clinical presentation of antiphospholipid-protein antibodies (APA).
Triplett DA
Thromb Haemost; 1995 Jul; 74(1):329-37. PubMed ID: 8578480
[TBL] [Abstract][Full Text] [Related]
32. [Antiphospholipid syndrome in females with recurrent fetal losses].
Krysova LA; Lesniak OM; Putilova NV; Remizova II
Klin Med (Mosk); 1999; 77(7):43-6. PubMed ID: 10483165
[TBL] [Abstract][Full Text] [Related]
33. Hemocoagulative pathology and immunological recurrent abortion.
Borrelli AL; Brillante M; Borzacchiello C; Berlingieri P
Clin Exp Obstet Gynecol; 1997; 24(1):39-40. PubMed ID: 9107457
[TBL] [Abstract][Full Text] [Related]
34. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome.
Branch DW; Silver R; Pierangeli S; van Leeuwen I; Harris EN
Obstet Gynecol; 1997 Apr; 89(4):549-55. PubMed ID: 9083311
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of anticardiolipin antibodies in women with recurrent miscarriage negative for the lupus anticoagulant.
Nielsen HS; Christiansen OB
Hum Reprod; 2005 Jun; 20(6):1720-8. PubMed ID: 15774545
[TBL] [Abstract][Full Text] [Related]
36. Anticardiolipin antibodies in women with recurrent abortion.
Daboubi MK
East Mediterr Health J; 2001; 7(1-2):95-9. PubMed ID: 12596957
[TBL] [Abstract][Full Text] [Related]
37. Antiphosphatidylethanolamine antibodies might not be an independent risk factor for further miscarriage in patients suffering recurrent pregnancy loss.
Obayashi S; Ozaki Y; Sugi T; Kitaori T; Katano K; Suzuki S; Sugiura-Ogasawara M
J Reprod Immunol; 2010 Jun; 85(2):186-92. PubMed ID: 20462639
[TBL] [Abstract][Full Text] [Related]
38. The prevalence of antiphospholipid antibodies in women with reproductive failure or major abruptio placentae.
van der Spuy ZM; Bird AR; Lindow SW; Bruce C
S Afr Med J; 1993 May; 83(5):319-21. PubMed ID: 8211423
[TBL] [Abstract][Full Text] [Related]
39. [Antiphospholipid sydrome--recurrent thrombosis and foetal loss due to antiphospholipid antibodies].
Elezović I; Matijević-Aleksić N; Rolović Z
Srp Arh Celok Lek; 1994; 122(5-6):179-81. PubMed ID: 17977423
[TBL] [Abstract][Full Text] [Related]
40. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome.
Rote NS
Obstet Gynecol; 1997 Oct; 90(4 Pt 1):642-4. PubMed ID: 9380335
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
